Citigroup’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-297
| Closed | -$2K | – | 5276 |
|
|
2019
Q3 | $2K | Sell |
297
-102
| -26% | -$687 | ﹤0.01% | 4995 |
|
|
2019
Q2 | $4K | Sell |
399
-262
| -40% | -$2.63K | ﹤0.01% | 4944 |
|
|
2019
Q1 | $18K | Sell |
661
-263
| -28% | -$7.16K | ﹤0.01% | 4571 |
|
|
2018
Q4 | $21K | Buy |
924
+269
| +41% | +$6.11K | ﹤0.01% | 4403 |
|
|
2018
Q3 | $36K | Buy |
655
+124
| +23% | +$6.82K | ﹤0.01% | 4281 |
|
|
2018
Q2 | $38K | Sell |
531
-18
| -3% | -$1.29K | ﹤0.01% | 4041 |
|
|
2018
Q1 | $33K | Buy |
549
+525
| +2,188% | +$31.6K | ﹤0.01% | 3989 |
|
|
2017
Q4 | $3K | Buy |
24
+13
| +118% | +$1.63K | ﹤0.01% | 4775 |
|
|
2017
Q3 | $1K | Sell |
11
-5
| -31% | -$455 | ﹤0.01% | 4660 |
|
|
2017
Q2 | $2K | Sell |
16
-92
| -85% | -$11.5K | ﹤0.01% | 4622 |
|
|
2017
Q1 | $20K | Sell |
108
-1,791
| -94% | -$332K | ﹤0.01% | 4073 |
|
|
2016
Q4 | $152K | Buy |
1,899
+1,389
| +272% | +$111K | ﹤0.01% | 3727 |
|
|
2016
Q3 | $39K | Buy |
510
+19
| +4% | +$1.45K | ﹤0.01% | 3867 |
|
|
2016
Q2 | $42K | Sell |
491
-1,237
| -72% | -$106K | ﹤0.01% | 3782 |
|
|
2016
Q1 | $160K | Buy |
1,728
+1,018
| +143% | +$94.3K | ﹤0.01% | 3655 |
|
|
2015
Q4 | $142K | Buy |
710
+624
| +726% | +$125K | ﹤0.01% | 3321 |
|
|
2015
Q3 | $13K | Sell |
86
-117
| -58% | -$17.7K | ﹤0.01% | 4289 |
|
|
2015
Q2 | $193K | Sell |
203
-172
| -46% | -$164K | ﹤0.01% | 2773 |
|
|
2015
Q1 | $275K | Sell |
375
-170
| -31% | -$125K | ﹤0.01% | 2701 |
|
|
2014
Q4 | $432K | Buy |
545
+444
| +440% | +$352K | ﹤0.01% | 2563 |
|
|
2014
Q3 | $40K | Sell |
101
-63
| -38% | -$25K | ﹤0.01% | 3831 |
|
|
2014
Q2 | $44K | Buy |
164
+56
| +52% | +$15K | ﹤0.01% | 3640 |
|
|
2014
Q1 | $24K | Sell |
108
-132
| -55% | -$29.3K | ﹤0.01% | 4404 |
|
|
2013
Q4 | $65K | Buy |
240
+239
| +23,900% | +$64.7K | ﹤0.01% | 4012 |
|
|
2013
Q3 | $0 | Sell |
1
-99
| -99% | – | ﹤0.01% | 5358 |
|
|
2013
Q2 | $14K | Buy |
+100
| New | +$14K | ﹤0.01% | 4338 |
|